Original news and analysis on international IP policy
A global business association held a meeting at the World Intellectual Property Organization this week on IP market developments, including increasing opportunities in technology transfer for commercial purposes. The intimate gathering featured a line-up of high-level speakers, including WIPO Director General Francis Gurry.
UNITAID, the drug purchasing facility affiliated with the World Health Organization, sees "great promise" in emerging diagnostic products for HIV treatment monitoring and diagnosis in remote regions. Now it is looking for someone to verify the freedom to operate of these tools, ensuring they are not intellectual property-encumbered.
World Health Organization Director General Margaret Chan today opened the 132nd meeting of the Executive Board, the UN agency’s highest authority, emphasising the importance of cost-effectiveness and results-driven operations at a time of global economic austerity and precarious funding.
The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.
A new innovation platform launched yesterday by Syngenta, the international agri-business company, means to broaden availability to some patented traits and technologies for vegetables, but also aims at opening new ways to use the intellectual property system.
The World Health Organization reports that unprecedented progress has been made in addressing 17 parasitic diseases affecting the world’s poorest populations. The public health authority attributes the gains, in large part, to the contributions of global partners, including drug contributions made by research-based pharmaceutical giants.
A Virginia-based company in the midst of a multi-million dollar merger is asserting patents on fundamental aspects of social networking it says have been infringed by Facebook, LinkedIn and three other companies. But even if the patents have validity, they come at a time of what may be a backlash against such lawsuits.
Intellectual property owners in the United States may be happy to see the end of 2012. Among the notable setbacks they suffered last year: Congress refused to expand remedies against online infringement, the Supreme Court raised the bar for patentable inventions, and lower courts repeatedly denied injunctions against patent infringement. It is unclear, however, if IP owners will fare better in 2013.
The United States Patent and Trademark Office and US Department of Justice yesterday issued a joint policy statement on standards essential patents that encourages voluntary technology licensing on fair, reasonable and non-discriminatory terms, and discourages injunctions or exclusionary orders that block infringing products from the market. Their advice to the International Trade Commission cites innovation, competition, consumers and the public interest.
What will 2013 bring for international intellectual property and innovation policy?
In the coming Intellectual Property Watch series for subscribers, our expert writers take a look at the top global policy issues and events in copyright, public health, legal battles, food security/biotech/biodiversity, trade, development, internet governance and more.
Depending on where one locates its advent, contemporary globalization is now more than half a century old. It might be asked whether globalization has been beneficial to Africa. One quick and easy way of addressing this often asked question is to cursorily look at the regional dynamics of over half century of globalization. And this leads to an urgent call for "homeland-Diaspora" intellectual property training, says Prof. Chidi Oguamanam.
For decades, the United States has pioneered the patenting of human genes, and other countries have followed this lead. But the US will soon perform an abrupt about-face, most experts predict. When the US Supreme Court hands down its decision in Association for Molecular Pathology v. Myriad Genetics, the justices appear likely to rule that human genes are not patentable subject matter. And the ruling may go even farther, holding that other forms of human DNA are not patentable.